TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Novartis Norge AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
820,521
|
1,005,266
|
973,368 |
Financial expenses |
546
|
646
|
1,467 |
Earnings before taxes |
27,320
|
43,368
|
36,808 |
Total assets |
418,561
|
329,774
|
353,963 |
Current assets |
411,844
|
327,721
|
349,403 |
Current liabilities |
235,806
|
159,226
|
188,756 |
Equity capital |
182,511
|
170,214
|
129,547 |
- share capital |
1,060
|
1,118
|
1,061 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
43.6%
|
51.6%
|
36.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.3%
|
4.3%
|
3.8% |
Return on assets (ROA) |
6.7%
|
13.3%
|
10.8% |
Current ratio |
174.7%
|
205.8%
|
185.1% |
Return on equity (ROE) |
15.0%
|
25.5%
|
28.4% |
Change turnover |
-131,943
|
-20,551
|
-4,743 |
Change turnover % |
-14%
|
-2%
|
0% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.